Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
TipRanks Clinical-Trials-Auto-Generated Newsdesk
TipRanks Reporter
TipRanks’s Recent Articles
Nanexa AB’s Phase 1 Study on NEX-22A: A Potential Game-Changer for Diabetes Treatment?
Nanexa AB (($DE:40M)) announced an update on their ongoing clinical study. Study Overview: The recent clinical study by...
7m ago
40M
Sanofi’s Pediatric Study on Unexplained Splenomegaly: Key Insights for Investors
Sanofi (($SNYNF)) announced an update on their ongoing clinical study. Sanofi has completed a non-interventional national study titled...
7m ago
SNYNF
Hofseth Biocare’s Salmon Bone Meal Study: A Potential Game-Changer for Bone Health
Hofseth Biocare ASA (($HOFBF)) announced an update on their ongoing clinical study. Hofseth Biocare ASA has recently completed...
7m ago
HOFBF
Ipsen’s New Study on Odevixibat: Long-term Insights for PFIC Treatment
Ipsen (($GB:0MH6)) announced an update on their ongoing clinical study. Study Overview: Ipsen is launching a new study...
1d ago
0MH6
Eli Lilly’s Diabetes Study: A New Chapter in Treatment Advancements
Eli Lilly And Company (($LLY)) announced an update on their ongoing clinical study. Study Overview: Eli Lilly and...
1d ago
LLY
Eli Lilly’s Olomorasib Study: A Step Forward in Hepatic Impairment Treatment
Eli Lilly And Company (($LLY)) announced an update on their ongoing clinical study. Study Overview: Eli Lilly and...
1d ago
LLY
AbbVie’s Promising Study on GUB014295: A Potential Breakthrough in Weight Management
Abbvie (($ABBV)) announced an update on their ongoing clinical study. AbbVie is currently conducting a two-part clinical study...
4d ago
ABBV
Alnylam Pharmaceuticals Completes Phase 1 Study of ALN-AGT01 RVR
Alnylam Pharmaceuticals (($ALNY)) announced an update on their ongoing clinical study. Alnylam Pharmaceuticals recently completed a Phase 1...
4d ago
ALNY
AstraZeneca’s Latest Study on Budesonide-Formoterol: Key Insights for Investors
AstraZeneca (($AZN)) announced an update on their ongoing clinical study. Study Overview: AstraZeneca recently completed a clinical study...
5d ago
AZN
AstraZeneca’s HER2-low Breast Cancer Study: Key Insights and Market Implications
AstraZeneca (($AZN)) announced an update on their ongoing clinical study. AstraZeneca has recently completed a significant study titled...
5d ago
AZN
Eli Lilly’s Orforglipron Study: A Potential Game-Changer in Obesity and Diabetes Treatment
Eli Lilly And Company (($LLY)) announced an update on their ongoing clinical study. Study Overview: Eli Lilly and...
5d ago
LLY
Argenx Completes Phase 1 Study on ARGX-109: Key Insights for Investors
Argenx (($ARGX)) announced an update on their ongoing clinical study. Argenx has recently completed a Phase 1 clinical...
5d ago
ARGX
GSK’s New COPD Study: A Potential Game-Changer?
GlaxoSmithKline (($GSK)) announced an update on their ongoing clinical study. GlaxoSmithKline (GSK) is launching a new clinical study...
6d ago
GSK
AbbVie’s Phase 3 Pediatric Constipation Study Completes, Potential Market Impact Looms
Abbvie (($ABBV)) announced an update on their ongoing clinical study. AbbVie, in collaboration with Ironwood Pharmaceuticals, has completed...
6d ago
ABBV
AbbVie’s Psoriasis Study Completes: Key Insights for Investors
Abbvie (($ABBV)) announced an update on their ongoing clinical study. AbbVie has recently completed a clinical study titled...
6d ago
ABBV
Eli Lilly’s New Phase 3 Study: A Potential Game-Changer in Advanced Breast Cancer Treatment
Eli Lilly And Company (($LLY)) announced an update on their ongoing clinical study. Eli Lilly and Company, in...
8d ago
LLY
Eli Lilly’s New Study: A Potential Breakthrough in Chemotherapy-Induced Nausea Treatment
Eli Lilly And Company (($LLY)) announced an update on their ongoing clinical study. Eli Lilly and Company is...
11d ago
LLY
Herantis Pharma’s HER-096 Study: A Step Forward in Parkinson’s Treatment
Herantis Pharma Plc (($FI:HRTIS)) announced an update on their ongoing clinical study. Herantis Pharma Plc has recently completed...
11d ago
HRTIS
Jazz Pharmaceuticals’ ZW25 Study Update: A Potential Game-Changer in Cancer Treatment
Jazz Pharmaceuticals (($JAZZ)) announced an update on their ongoing clinical study. Jazz Pharmaceuticals recently updated its Phase 2...
11d ago
JAZZ
GSK’s New Study on Bepirovirsen: A Potential Game-Changer for Hepatitis B Treatment?
GlaxoSmithKline (($GSK)) announced an update on their ongoing clinical study. GlaxoSmithKline (GSK) is conducting a Phase 1 study...
12d ago
GSK
AstraZeneca’s OLIVIA Study: Advancing Ovarian Cancer Care in Brazil
AstraZeneca (($AZN)) announced an update on their ongoing clinical study. Study Overview: The OLIVIA Study, officially titled ‘Ovarian...
12d ago
AZN
AbbVie’s ABBV-1088 Study: A Closer Look at Recent Developments
Abbvie (($ABBV)) announced an update on their ongoing clinical study. AbbVie is conducting a Phase 1 clinical study...
12d ago
ABBV
Eli Lilly’s Phase 1 Study of LY3985297: Key Insights for Investors
Eli Lilly And Company (($LLY)) announced an update on their ongoing clinical study. Study Overview: Eli Lilly and...
12d ago
LLY
Eli Lilly’s Pirtobrutinib Study: A Long-Term Safety Evaluation in Blood Cancers
Eli Lilly And Company (($LLY)) announced an update on their ongoing clinical study. Study Overview: Eli Lilly and...
14d ago
LLY
Eli Lilly Completes Key Phase 1 Study on LY4065967: Market Implications
Eli Lilly And Company (($LLY)) announced an update on their ongoing clinical study. Eli Lilly and Company recently...
14d ago
LLY
AstraZeneca’s AZD2389 Phase I Study Completion: Key Insights for Investors
AstraZeneca (($AZN)) announced an update on their ongoing clinical study. AstraZeneca has recently completed a Phase I clinical...
14d ago
AZN
Cardinal Health’s Real-world Study on HPV-positive Cancer Treatment: Key Insights
Cardinal Health (($CAH)) announced an update on their ongoing clinical study. Study Overview: The study titled Real-world Study...
14d ago
CAH
AstraZeneca’s PROVIDENCE Study: Real-world Insights into Trastuzumab Deruxtecan for Metastatic Breast Cancer
AstraZeneca (($AZN)) announced an update on their ongoing clinical study. Study Overview: AstraZeneca is conducting a study titled...
16d ago
AZN
Regeneron’s Innovative Cancer Study: A Potential Game-Changer for Advanced Tumors
Regeneron Pharmaceuticals (($REGN)) announced an update on their ongoing clinical study. Regeneron Pharmaceuticals is conducting a clinical study...
16d ago
REGN
Regeneron Advances Melanoma Treatment with Long-term Study Update
Regeneron Pharmaceuticals (($REGN)) announced an update on their ongoing clinical study. Study Overview: Regeneron Pharmaceuticals is conducting a...
16d ago
REGN
Regeneron’s Latest Clinical Study on Advanced NSCLC: A Potential Game Changer?
Regeneron Pharmaceuticals (($REGN)) announced an update on their ongoing clinical study. Regeneron Pharmaceuticals is conducting a clinical study...
16d ago
REGN
Sanofi’s Promising Ulcerative Colitis Study: What Investors Need to Know
Sanofi (($SNYNF)) announced an update on their ongoing clinical study. Sanofi is conducting a clinical study titled ‘A...
16d ago
SNYNF
Celldex Therapeutics Advances in Prurigo Nodularis Treatment with Barzolvolimab Study
Celldex Therapeutics (($CLDX)) announced an update on their ongoing clinical study. Study Overview: Celldex Therapeutics is conducting a...
16d ago
CLDX
AstraZeneca’s Promising Phase II Study on AZD0901 for Advanced Solid Tumors
AstraZeneca (($AZN)) announced an update on their ongoing clinical study. AstraZeneca is currently conducting a Phase II clinical...
16d ago
AZN
AstraZeneca’s Latest Phase 4 Study: A Boost for HER2-Positive Breast Cancer Treatment?
AstraZeneca (($AZN)) announced an update on their ongoing clinical study. Study Overview: AstraZeneca is conducting a Phase 4...
16d ago
AZN
AstraZeneca’s Tezepelumab Study: A Potential Game-Changer for COPD Treatment
AstraZeneca (($AZN)) announced an update on their ongoing clinical study. AstraZeneca, in collaboration with Amgen, is conducting a...
16d ago
AZN
Eli Lilly’s New Study on LY3537031: A Potential Game-Changer in Weight Management?
Eli Lilly And Company (($LLY)) announced an update on their ongoing clinical study. Eli Lilly and Company is...
16d ago
LLY
OSE Immunotherapeutics Advances Phase 3 Trial for NSCLC Vaccine
OSE Immunotherapeutics (($DE:6OP)) announced an update on their ongoing clinical study. OSE Immunotherapeutics is conducting a pivotal Phase...
16d ago
6OP
Eli Lilly’s New Phase 1 Study: A Potential Game Changer?
Eli Lilly And Company (($LLY)) announced an update on their ongoing clinical study. Eli Lilly and Company is...
16d ago
LLY
AstraZeneca and AbbVie: New Phase II Study Targets Relapsed CLL/SLL
AstraZeneca (($AZN)), Abbvie (($ABBV)) announced an update on their ongoing clinical study. Study Overview: The MAVRiC Study, officially...
16d ago
AZN
ABBV
Regeneron’s Promising NSCLC Study: A Game Changer in Cancer Treatment?
Regeneron Pharmaceuticals (($REGN)) announced an update on their ongoing clinical study. Regeneron Pharmaceuticals is currently conducting a study...
16d ago
REGN
Sanofi’s Promising Crohn’s Disease Study: What Investors Need to Know
Sanofi (($SNYNF)) announced an update on their ongoing clinical study. Study Overview: Sanofi is conducting a Phase 2...
16d ago
SNYNF
AbbVie’s ABBV-525 Study: A Potential Game-Changer in B-Cell Malignancies
Abbvie (($ABBV)) announced an update on their ongoing clinical study. AbbVie is conducting a first-in-human study titled ‘A...
16d ago
ABBV
Gilead Sciences Advances GS-4321 Study for Chronic Hepatitis Delta
Gilead Sciences (($GILD)) announced an update on their ongoing clinical study. Gilead Sciences is currently conducting a clinical...
16d ago
GILD
Avidity Biosciences’ Promising Phase 3 Study on Del-desiran for DM1: What Investors Need to Know
Avidity Biosciences Inc (($RNA)) announced an update on their ongoing clinical study. Study Overview: Avidity Biosciences Inc. is...
16d ago
RNA
Eli Lilly’s Gene Therapy Trial: A Potential Breakthrough in Hearing Loss Treatment
Eli Lilly And Company (($LLY)) announced an update on their ongoing clinical study. Study Overview: The clinical trial...
16d ago
LLY
Sanofi’s Amlitelimab Study: A Potential Game-Changer for Atopic Dermatitis
Sanofi (($SNYNF)) announced an update on their ongoing clinical study. Sanofi is conducting a long-term extension study titled...
16d ago
SNYNF
AstraZeneca’s Tezepelumab Study: A Potential Game-Changer for COPD Treatment
AstraZeneca (($AZN)) announced an update on their ongoing clinical study. AstraZeneca, in collaboration with Amgen, is conducting a...
16d ago
AZN
EXACT Therapeutics’ Promising Pancreatic Cancer Study: A Closer Look
EXACT Therapeutics AS (($DE:56F)) announced an update on their ongoing clinical study. EXACT Therapeutics AS is conducting a...
16d ago
56F
Gilead Sciences Advances Pediatric HIV Treatment with New Study Update
Gilead Sciences (($GILD)) announced an update on their ongoing clinical study. Gilead Sciences is conducting a Phase 2/3...
16d ago
GILD
SHOW MORE
You need to enable JavaScript to run this app.
